UZ | University of Zimbabwe

Chairperson

Dr Ntokozo Ndlovu

Qualifications: Master of Medical Science Degree in Clinical Epidemiology (MMed Sci: Clin Epi), University of Newcastle, Australia, 2002. Master of Medicine Degree in Radiotherapy and Oncology (MMed Rad & Onco), University of Zimbabwe, Zimbabwe, 1993. Bachelor of Medicine and Bachelor of Surgery Degrees with Honours in Biochemistry (MB ChB), University of Zimbabwe, Zimbabwe, 1985.

Dr Ntokozo Ndlovu is the Chairperson of the Department of Oncology in the Faculty of Medicine and Health Sciences (FMHS). She is a Clinical/Radiation Oncologist by profession and a Clinical Epidemiologist/Cancer Researcher. She was Course Coordinator of the Master of Medicine Degree in Radiotherapy and Oncology (MMed Rad & Onco) for 25 years till July 2020. She is also the Chairperson of the Division of Radiotherapy and Oncology - Radiotherapy Centre - Parirenyatwa Group of Hospitals, Harare, Zimbabwe where she conducts clinical practice and clinical teaching. She is responsible for the administrative running of the centre that serves as the tertiary referral centre for the treatment of cancer covering most of the country. She contributed to the rehabilitation of the radiotherapy treatment and clinical teaching facilities at Mpilo Central Hospital, Bulawayo. The refurbishment of these units saw the introduction of modern treatment techniques in the country coupled with the necessary staff training to achieve that.

In cancer research, she has a special interest in areas relevant to improving the lives and treatment of people with cancer in Zimbabwe and the region, to include HIV and cancer, equity/access to cancer treatment and capacity building in cancer management. She is the Chairperson of the Non-communicable Diseases Research Group in the FMHS and the Cancer Research Sub-Group thereof. Dr. Ndlovu is also the International Vice Chairperson for the Solid Tumour Working Group for the AIDS Malignancy Consortium (AMC), National Cancer Institute, USA and an International Activities Subcommittee member. She has engaged in protocol development, served as Principal Investigator and Protocol Chair for some AMC African studies. As research supervisor, she has mentored international and local young researchers out of interest in developing cancer researchers and institutional research capacity.

As part of work done in the African region, she was the Project Scientific Consultant of the International Atomic Energy Agency (IAEA) Regional Radiotherapy Project for 3 successive terms (2008- 2019) This entailed working with IAEA Technical Officers and regional national project coordinators of the IAEA Member States, to identifying gaps and make recommendations of solutions to radiotherapy treatment and management problems common to African Member States. She was the elected President of the African Radiation Oncology Group (AFROG) from 2009 - 2013. She is a member of the African Cancer Coalition a regional body that is harmonizing international cancer treatment guidelines (NCCN) to be suitable for use in the African continent in collaboration with the American Cancer Society. The Coalition is also responsible for collaboration with Chemo-Safe to promote the safe handling and administration of chemotherapy drugs in the region.

Nationally, she contributed towards the development of the National Cancer Prevention and Control Strategy, as the Chairperson of the National Coalition for Cancer Committee responsible for the strategy development in 2012 and led the subcommittee on Cancer Diagnosis and Treatment for the same. She is the Chairperson of the Technical Working Group for the revision of Oncology in Zimbabwe National Cancer Treatment Guidelines. As a member of the National Palliative Care Integration Taskforce, she contributed to the Monitoring, Evaluation and Research Technical Working Group thereof and is a committee member of the Palliative Care National Advisory Steering Committee.

As Vice Chairperson and Member of the Executive Committee for the National Cancer Registry Advisory Committee, she serves in the editorial board for the Pattern of Cancer in Zimbabwe -National Cancer Registry Annual Reports that provide the national statistics on cancer incidence and mortality. This registry is one of the few African cancer registries recognized internationally. As Board chairperson of the Radiation Protection Authority of Zimbabwe (2010 to 2019), she was responsible for overseeing the mandate to protect people and the environment from the harmful effects of radiation nationally.

Senior Lecturer

Dr Pasipanodya Nziramasanga

List of Published Articles

P. Nziramasanga & David M. Lupan (1985) : Elastase activity of Coccidioides Immitis. Journal of Medical Microbiology Vol. 19 page 109-114.

P Nziramasanga & D.M. Lupan (1985: Elastase activity of Fungi with Anamorphs similar to Coccidioidis immitis. Mycopathologia, Dec,92 (3) page 169-71.

P Nziramasanga & P M Shah and W. Stille (1993): Control of intracellular growth of Mycobacterium fortuitum by human monocytes in vitro. Journal of Chemotherapy Vol. 5 (2) Page 103 – 106.

P. Nziramasanga & D.M. Lupan (1986): Collagenolytic activity of Coccidiodes immitis.Infection and Immunity 52 (1) page 360 – 361

P. Nziramasnga, P.M. Shah and W. Stille (1993): Resistance of Mycobacterium fortuitum to killing by Monocytes- Derived Macrophages. Rev. Espanol Quimioterapia Macrh Vol. 6 (1)

D.T Mcleod, P. Neil, J.R. Robertson, A.S. Latif, J.C. Emmanuel, J.E. Els, L.K.Z. Gwanzura, F.E.J.Trijssenaar, P. Nziramasanga, G.R. Jongeling, D.A. Katzenstein, N. Nkanga and S.B. Lucas (1989): Pulmonary disease in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, pg 694-97

Interviews E.W., Ch. A Thomas, P. Nziaramasanga, P. Kurz, J. Vlachoyannis and P.M. Shah (1990): Influence of Ciprofloxacin on the Phagocystosis of Staphylococci, E. coli and P. aeruginosa by Human Peritoneal Macrophages. Revista espanol de Quimioterapia 3 (3): pg 137 – 40

P. Nziramasnga, P.M. Shah and W. Stille. (1995): Intercellular Antimycobacterial activity of ciprofloxacin and ofloxacin in Mycobacterium fortuitum infected human polymorphonuclear leukocytes. International Journal of Immunopathology and Pharmacology Vol. 8, no. 3: pg 209 – 215

C.L. Obi, B. Makandiramba, V. Robertson, S.A Tswana, S.R. Moyo, P. Nziramasanga (1998): In viro activity of piperacillin and tazobactam combination against clinically significant bacteria.. East Africa Medical Journal, Vol 75, no 3: pg 161 – 164

Obi C.L., Makandiramba B, Tswana S.A., Robertson V.J., Moyo S.R., Nziramasanga P (1999): In-vitro disk diffusion sensitivity of meropenem against bacterial pathogens in Harare. East Africa Medical Journal 76 365

R.T. Mavenyengwa and P. Nziramasanga (2003): Use of culture methods for recovery of atypical mycobacteria from stools of AIDS patients. Central African Journal of Medicine Vol49 (3/4); pg 31-37, 2003

R.T. Mavenyengwa, P. Masunga, E. Meque, T. Kudinha, S.R. Moyo, L. Bevanger, K. Bergh, P. Nziramasanga and T. Mapako (2006): Streprococcus agalactiae (Group B Streptococcus (GBS) colonization and persistence in pregnancy; a comparison of two diverse communities (rural and urban). Central Africa Journal of Medicine Vol52 (3/4); pg 8-13, 2006

Mtapuri-Zinyowera S, Ruhanya V, Midzi N, Berejena C, Chin'ombe N, Nziramasanga P, Nyandoro G, Mduluza T. (2014): Human parasitic protozoa in drinking water sources in rural Zimbabwe and their link to HIV infection. Germs. Dec 1;4(4):86-91

Mukaratirwa A, Berejena C, Nziramasanga P, Shonhai A, Mamvura TS, Chibukira P, Mucheuki I, Mangwanya D, Kamupota M, Manangazira P, Tapfumaneyi C, Gerede R, Munyoro M, Mwenda JM, Mphahlele JM, Seheri ML, Peenze I, Gonah AN, Maruta A, Tengende MB (2014): Epidemiologic and genotypic characteristics of rotavirus strains detected in children less than 5 years of age with gastroenteritis treated at 3 pediatric hospitals in Zimbabwe during 2008-2011. Pediatr Infect Dis J. Jan;33 Suppl 1:S45-8.

Chimhuya S, Manangazira P, Mukaratirwa A, Nziramasanga P, Berejena C, Shonhai A, Kamupota M, Gerede R, Munyoro M, Mangwanya D, Tapfumaneyi C, Byabamazima C, Shibeshi EM, Nathoo KJ. (2015): Trends of rubella incidence during a 5-year period of case based surveillance in Zimbabwe. BMC Public Health. Mar 27;15:2 94.

Mamvura TS, Chin'ombe N, Ruhanya V, Nziramasanga P. (2015): Seroprevalence of rubella virus IgG in pregnant women in Harare, Zimbabwe. Germs.2 Jun 5(2):50-2

L. Padya, N. Chin’ombe, M. Magwenzi, J. Mbanga, P. Nziramasanga (2015): Molecular Identification of Mycobacterium Species of Public Health Importance In Cattle In Zimbabwe by 16s RNA Gene Sequencing. The Open Microbiology Journal Vol 9, pg 1-12

Chin’ombe N., E. Munemo, M. Magwenzi, B. Muzividzi and Nziramasanga P. (2015) First cases of Mycobacterium elephantis in Zimbabwe revealed by 16 S Ribosequencing Archives of Clinical Microbiology Vol 6 (4) : 10 1-3

Chin’ombe N., B. Muzividzi, E. Munemo, Nziramasanga P. (2016) : Molecular identification of Nontuberculous Mycobacteria in humans in Zimbabwe using 16S Ribosequencing. The Open Microbiology Journal Vol 10 : 3-13
Musona-Rukweza J., C. Haruzivishe, F. Muchabaiwa Gidiri, P.Nziramasanga and B. Stray-Pedersen (2017) Asymptomatic Bacteriuria in Pregnancy : A concept Analysis Journal of Microbiology Research and Reviews Vol 4 (1) : 1 – 5

21. Matare T., Nziramasanga P., Gwanzura L. and Robertson V. (2017) Experimental germ tube induction in Candida albicans : An evaluation of the effect of sodium bicarbonate on morphogenesis and comparison with pooled human serum. BioMedResearch International Volume 2017 (2017), Article ID 1976273: 1 –5 https/doi.org/10.1155/2017/1976273

Musona-Rukweza J., Gidiri Muchabaiwa F., Nziramasanga P., Stray-Pedersen Babill and Haruzivishe C. O. (2017) Isolated Bacterial Uropathogens among Pregnant Women Diagnosed with Asymptomatic Bacteriuria in Harare, Zimbabwe Microbiology Research Journal International Vol 22 (3) : 1 – 7

Musona –Rukweza J., Nziramasanga P., Gidiri Muchabaiwa F., Haruzivishe C. O. and Stray-Pedersen Babil (2017) Effectiveness of Griess Nitrite Test on Screening Asymptomatic Bacteriuria in Pregnancy : A Cross Sectional Study in Harare, Zimbabwe Journal of Advances in Microbiology Vol 5 (2) : 1 - 9

Musona-Rukweza J., F. Gidiri Muchabaiwa, P. Nziramasanga, C. Haruzivishe and B. Stray-Pedersen (2017) Prevalence of asymptomatic bacteriuria among pregnant women: a cross-sectional study in Harare, Zimbabwe. Perinatal Journal Vol 25 (4) : 133 – 138
Musona-Rukweza J., Nziramasanga P, Muchabaiwa Gidiri F., Haruzivishe C. O and Stray-Pedersen B. (2018) Antibiotic susceptibility of bacterial strains causing asymptomatic bacteriuria in pregnancy : A cross-sectional study in Harare, Zimbabwe MOJ Immunology 2018, Volume 6 (1) : 00184 : page 1 - 6.

Lecturer

Dr Justen Manasa

List of Publications

Tzou PL, Rhee SY, Pond SLK, Manasa J, Shafer RW. Selection analyses of paired HIV-1 gag and gp41 sequences obtained before and after antiretroviral therapy. Sci Data. 2018 Jul 24;5:180147. doi: 10.1038/sdata.2018.147. PubMed PMID: 30040081; PubMed Central PMCID: PMC6057438.
Chimukangara B, Manasa J, Mitchell R, Nyabadza G, Katzenstein D, et al. Community Based 3Antiretroviral Treatment in Rural Zimbabwe. AIDS Res Hum Retroviruses. 2017 Sep 13;PubMed PMID: 28899102.
Manasa J, Varghese V, Pond SLK, Rhee SY, Tzou PL, et al. Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors. Sci Rep. 2017 Sep 14;7(1):11559. PubMed PMID: 28912582.
Ratmann O, Wymant C, Colijn C, Danaviah S, Essex M, et al. HIV-1 full-genome phylogenetics of generalized epidemics in sub-Saharan Africa: impact of missing nucleotide characters in next-generation sequences. AIDS Res Hum Retroviruses. 2017 May 25;PubMed PMID: 28540766; NIHMSID: EMS73006; PubMed Central PMCID: PMC5597042.
Chimukangara B, Varyani B, Shamu T, Mutsvangwa J, Manasa J, et al. HIV drug resistance testing among patients failing second line antiretroviral therapy Comparison of in-house and commercial sequencing. J Virol Methods. 2017 May;243:151-157. PubMed PMID: 27894862; NIHMSID: NIHMS854678; PubMed Central PMCID: PMC5393912.
Modukanele K, Sherwin J, White E, Manasa J, Zijenah LS, et al. Envelope Tropism and Diversity of Subtype C HIV among pregnant Women in Zimbabwe. Clinical Research in HIV/ AIDS. 2017 April 28; 4(2):1038.
Rossouw TM, Nieuwoudt M, Manasa J, Malherbe G, Lessells RJ, et al. HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa. HIV Med. 2017 Feb;18(2):104-114. PubMed PMID: 27353262.
Manasa J, Danaviah S, Lessells R, Elshareef M, Tanser F, et al. Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa. AIDS Res Hum Retroviruses. 2016 Aug;32(8):763-9. PubMed PMID: 27002368; PubMed Central PMCID: PMC4971422.
Manasa J, Katzenstein D. Editorial Commentary: Scaling Up Antiretroviral Therapy in Africa: Are We There Yet?. Clin Infect Dis. 2016 Feb 15;62(4):519-20. PubMed PMID: 26561533.
Manhanzva MT, Mutsvangwa J, Beck IA, Frenkel LM, Tshabalala M, et al. The Burden of HIV Associated Drug Resistance Mutations in an Early Infant Diagnosis Program: A Glance through the Paediatric Window of Zimbabwe. Infectious Diseases and Therapy . 2015; 3(1).
Kiepiela P, Manasa J, Moosa M, Moodley P, Gordon M, et al. HIV Drug Resistance Patterns at the Epicentre of the HIV-1 Epidemic in KwaZulu-Natal, South Africa 2003-2013. Journal of AIDS & clinical research. 2014 April 25; 5(5).
Manasa J, Danaviah S, Pillay S, Padayachee P, Mthiyane H, et al. An affordable HIV-1 drug resistance monitoring method for resource limited settings. J Vis Exp. 2014 Mar 30;(85)PubMed PMID: 24747156; NIHMSID: EMS58421; PubMed Central PMCID: PMC4024245.
Lessells RJ, Stott KE, Manasa J, Naidu KK, Skingsley A, et al. Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges. BMC Health Serv Res. 2014 Mar 7;14:116. PubMed PMID: 24606875; PubMed Central PMCID: PMC3973961.
Pillay S, Bland RM, Lessells RJ, Manasa J, de Oliveira T, et al. Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort. AIDS Res Ther. 2014 Jan 20;11(1):3. PubMed PMID: 24444369; PubMed Central PMCID: PMC3922737.
Manasa J, Lessells R, Rossouw T, Naidu K, Van Vuuren C, et al. Southern African Treatment Resistance Network (SATuRN) RegaDB HIV drug resistance and clinical management database: supporting patient management, surveillance and research in southern Africa. Database (Oxford). 2014;2014:bat082. PubMed PMID: 24504151.
Singh L, Parboosing R, Manasa J, Moodley P, de Oliveira T. High level of HIV-2 false positivity in KwaZulu-Natal province: a region of South Africa with a very high HIV-1 subtype C prevalence. J Med Virol. 2013 Dec;85(12):2065-71. PubMed PMID: 23959597.
Manasa J, Lessells RJ, Skingsley A, Naidu KK, Newell ML, et al. High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa. PLoS One. 2013;8(8):e72152. PubMed PMID: 23991055; PubMed Central PMCID: PMC3749184.
Manasa J, Katzenstein D, Cassol S, Newell ML, de Oliveira T. Primary drug resistance in South Africa: data from 10 years of surveys. AIDS Res Hum Retroviruses. 2012 Jun;28(6):558-65. PubMed PMID: 22251009; PubMed Central PMCID: PMC3358100.
Tshabalala M, Manasa J, Zijenah LS, Rusakaniko S, Kadzirange G, et al. Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe. PLoS One. 2011;6(6):e21241. PubMed PMID: 21698125; PubMed Central PMCID: PMC3116901.
de Oliveira T, Shafer RW, Seebregts C. Public database for HIV drug resistance in southern Africa. Nature. 2010 Apr 1;464(7289):673. doi: 10.1038/464673c. PubMed PMID: 20360715; PubMed Central PMCID: PMC4767176.
Dalai SC, de Oliveira T, Harkins GW, Kassaye SG, Lint J, et al. Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe. AIDS. 2009 Nov 27;23(18):2523-32. PubMed PMID: 19770693; NIHMSID: NIHMS191722; PubMed Central PMCID: PMC2923658.
Manasa J, Musabaike H, Masimirembwa C, Burke E, Luthy R, et al. Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe. Clin Vaccine Immunol. 2007 Mar;14(3):293-8. PubMed PMID: 17267593; PubMed Central PMCID: PMC1828850.

Lecturer

Dr Rachael Mandishora

Achievements

Attained Doctor of Philosophy Degree in Molecular Virology, 2018.
Completed a UZ-PERFECT (Promoting Excellence in Research and Faculty Enhanced Career Training) fellowship 2016-2018.
Currently a Clayton-Dedonder Fellow.

List of publications:

Racheal S. Dube Mandishora, Kristina S Gjøtterud, Sonja Lagström, Babill Stray-Pedersen, Nyasha Chin'ombe, Kerina Duri, Mari Nygård, Irene Kraus Christiansen, Ole Herman Ambur, Mike Z. Chirenje, Trine B Rounge. Intra-host sequence variability in human papillomavirus. Papillomavirus Research, 2018 April 30. https://doi.org/10.1016/j.pvr.2018.04.006

Racheal S. Dube Mandishora, Irene K. Christiansen, Nyasha Chin’ombe, Kerina Duri, Bernard Ngara, Trine B. Rounge, Roger Meisal, Ole Herman Ambur, Joel M. Palefsky, Babill Stray-Pedersen, Zvavahera M. Chirenje. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe (Journal of Medical Virology, 2017 Apr 8. doi: 10.1002/jmv.24825.

Faustinos Tatenda Takawira, Racheal Shamiso Dube Mandishora, Zephaniah Dhlamini, Ellen Munemo, Babill Stray-Pedersen. Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods. The Pan African Medical Journal. 2017;27:145. doi:10.11604/pamj.2017.27.145.10883
Takudzwa Matuvhunye, Racheal S Dube-Mandishora, Nyasha, Chin’ombe, Graham Chakafana, Joshua Mbanga, Edward Zumbika, Babill Stray-Pedersen. Genotyping Human Papillomavirus in Women Attending Cervical Cancer Screening Clinic In Harare, Zimbabwe. British Microbiology Research Journal 16(6): 1-9, 2016, Article no.BMRJ.28481
Dube-Mandishora Racheal S, Dhlamini Zephaniah, Mutetwa Reggie, Duri Kerina, Stray-Pedersen Babill, Mason Peter. Diagnosis of multi - drug resistant Tuberculosis mutations using Hain line probe assay and GeneXpert: a study done in Zimbabwe. British journal of medicine and medical research. 2014. 5(8): 1044-1052.

Senior Lecturer

Professor Nyasha Chin’ombe

PhD in Medical Microbiology (UCT), MSc in Biotechnology (UZ), BSc in Biological Sciences (UZ)

Outstanding Achievements

University of Zimbabwe Research Board funding: Mycobacteria Research project: 2015-2018.
Claude Leon Foundation Postdoctoral Fellowship, 2011-2012: University of Cape, Cape Town, Division of Human Genetics. RSA.
Emory-South Africa NRF Drug Discovery Post-doctoral Fellowship, 2010-11: Emory Vaccine Center, Emory University, Atlanta, USA.
Global HIV Vaccine Enterprise scholarship to attend 5th African AIDS Vaccine Programme (AAVP) Forum, 13-15 December, 2009, Kampala, Uganda.
Bill & Melinda Gates Foundation Award for registration subsidy of the Keystone Conference on Overcoming the Crisis of TB and AIDS. Arusha, Tanzania, October, 2009.
International Society for Infectious Diseases scholarship for registration for the 13th International Conference on Infectious Diseases Conference, Kuala Lumpur, June 2008.
National Research Foundation/University of Cape Town Travel fellowship to attend the 13th International Conference on Infectious Diseases Conference, Kuala Lumpur, June 2008.
International 2008 AIDS Vaccine Complementary Registration Scholarship to attend 2008 International AIDS Vaccine Conference in Cape Town, South Africa, October, 2008.
Global Health Travel Award to attend Keystone Symposia on Challenges of Global Vaccine Development, Cape Town, South Africa, October 2007.
NRF SARChI Chair postdoctoral fellowship, 2007-2009,UCT.
World Health Organization scholarship to attend 7th Global Vaccine Research Forum in Bangkok, Thailand, Dec. 2006.
International 2005 AIDS Vaccine Scholarship to attend 2005 AIDS Vaccine Conference in Montreal, Canada, September 2005.
Africa Genome Institute 2005 Fellowship to attend the Africa Genome Conference in Nairobi, March 2005.
International 2004 AIDS Vaccine Scholarship to attend AIDS Vaccine Conference in Lausanne, Switzerland, September 2004.
South African AIDS Vaccine Initiative (SAAVI) Scholarship to study PhD in Medical Microbiology (Virology) at University of Cape Town, 2001-2006..
International Livestock Research Institute Graduate Fellowship to do MSc (Biotechnology) research project at the Institute, 1996.
Hiram Wild Memorium Prize and University Book Prizes for being best student in Coursework and Examination for the BSc Honours degree in Biological Sciences, 1993.

Lis of Publications

Dube Mandishora RS, Gjøtterud KS, Lagström S, Stray-Pedersen B, Duri K, Chin'ombe N, Nygård M, Christiansen IK, Ambur OH, Chirenje MZ, Rounge TB. Intra-host sequence variability in human papillomavirus. Papillomavirus Res. 2018. 5:180-191.
Manjeese W, Muzividzi B, Mbanga J, Mufandaedza J, Chin’ombe N. RpoB Gene-Based Characterization of Non-Tuberculous Mycobacteria in Zimbabwe. Journal of Advances in Microbiology. 2017: 6(1): 2456-7116.
Dube-Mandishora RS, Christiansen IK, Chin'ombe N, Duri K, Ngara B, Rounge TB, Meisal R, Ambur OH, Palefsky JM, Stray-Pedersen B, Chirenje ZM. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe. J Med Virol. 2017;89:1671–1677.
Mbiri W, Chin’ombe N. Molecular Identification of Plasmodium Species in Malaria in Zimbabwe by Mitochondrial DNA Sequencing. International Journal of TROPICAL DISEASE & Health. 2017. 21(2): 1-8.
Sebata NL, Chin’ombe N. Molecular Detection and Typing of Genital Human Papillomavirus among Female Medical and Nursing Students in Harare, Zimbabwe. International STD Research & Reviews. 2017. 5(1): 1-8.
Baudi I, Iijima S, Chin’ombe N, Mtapuri-Zinyowera S, Murakami S, Isogawa M, Hachiya A, Iwatani Y, Tanaka Y. Molecular epidemiology of co-Infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe. Journal of Medical Virology. 2017. 89: 257-266.
Mandishora RSD, Christiansen IK, Chin'ombe N, Duri K, Rounge TB, Meisal R, Ambur OH, Stray-Pedersen B, Chirenje ZM. Do HIV-infected and Uninfected Women Have Different Human Papilloma Virus Genotypes Distribution: A Cross Sectional Study Carried out in Zimbabwe. AIDS Research & Human Restroviruses, 2016, 32 (Supplement 1): 280.
Nyazika TK, Hagen F, Machiridza T, Kutepa M, Masanganise F, Hendrick M, Boekhout T, Magombei T, Siziba T, Chin’ombe N, Mateveke K, Meis JF, Robertson VJ. Cryptococcus neoformans population diversity and clinical outcomes of HIV-associated cryptococcal meningitis patients in sub-Sahara Africa. Journal of Medical Microbiology. 2016. 65:1281-1288.
Chin’ombe N, Muzividzi B, Munemo E, Nziramasanga P. Molecular identification of nontuberculous mycobacteria in humans in Zimbabwe. 2016. International Journal of Infectious Diseases. 45 (Supplement 1): 169-170.
Matuvhunye T, Dube-Mandishora RS, Chin’ombe N, Chakafana G, Mbanga R, Zumbika, Stray-Pedersen B. Genotyping human papillomavirus in women attending cervical cancer screening clinic in Harare, Zimbabwe. 2016. British Microbiology Research Journal. 2016. 16(6): 1-9.
Chin’ombe N, Manjeese W, Munemo E. Molecular Detection of Mycobacterium tuberculosis Rifampicin Drug Resistance Using rpoB Gene Sequencing in Zimbabwe. British Microbiology Research Journal. 2016. 16(5): 1-6.
Chin’ombe N, Muzividzi B, Munemo M, Nziramasanga P. Molecular Identification of Nontuberculous Mycobacteria in Humans in Zimbabwe Using 16S Ribosequencing. The Open Microbiology Journal. 2016; 10, 3-13.
Matambo R, Nyandoro G, Mungofa S, Mutseyekwa FM, Ruhanya V, Mugomeri E, Chin’ombe N. Identifying factors associated with contracting typhoid during an outbreak in Harare, Zimbabwe. Journal of Contemporary Clinical Practice. 2016; 2: 9-17.
Kouamou V, Chin’ombe N, Matimba A, Kadzatsa W, Nyandoro G, Musarurwa C. P53 Codon 72 Polymorphism and the Risk of Cervical Cancer in Zimbabwean Women. International Journal of Tropical Disease and Health. 2016, 15(3): 1-6.
Matambo R, Duri C, Ruhanya V, Mungofa S, Chadambuka E, Nyandoro G, Mugomeri E, Chin’ombe N. Evaluation of a Tuberculosis Surveillance System in the Harare City Health Department in Zimbabwe. International Journal of Tropical Disease and Health. 2016, 14(4): 1-10.
Matambo R, Bare H, Mungofa S, Miti G, Ruhanya V, Nyandoro G, Chin’ombe N. Evaluation of the Antiretroviral Therapy Program at Wilkins Hospital in Zimbabwe. British Journal of Medicine & Medical Research. 2016; 11(4): 1-9.
Padya L, Chin’ombe N, Magwenzi M, Mbanga M, Nziramasanga P. Molecular identification of Mycobacterium species of public health importance in cattle in Zimbabwe by 16S rRNA gene sequencing. The Open Microbiology Journal. 2015; 9, 38-42.
Chin'ombe N, Munemo E, Magwenzi M, Muzividzi B, Nziramasanga N. First Cases of Mycobacterium elephantis in Zimbabwe Revealed by 16S Ribosequencing. Archives of Clinical Microbiology. 2015; 6:10.
Chin’ombe N, Ruhanya V. HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies. The Pan African Medical Journal. 2015;20:386.
Mugomeri E, Senauoane MB, Ruhanya V, Chin’ombe N, Nyandoro G, Occurrence of HBV/HIV coinfection by laboratory values in Roma, Lesotho. GERMS. 2015;5:8-11.
Tarupiwa A, Tapera S, Mtapuri-Zinyowera S, Gumbo P, Ruhanya V, Gudza-Mugabe M, Majuru NX, Chin’ombe N. Evaluation of TUBEX-TF and OnSite Typhoid IgG/IgM Combo Rapid Tests to Detect Salmonella enterica serovar Typhi During a Typhoid Outbreak in, Harare Zimbabwe. BMC Research Notes. 2015:8:50.
Mamvura TS, Chin’ombe N, Ruhanya V, Nziramasanga P. Seroprevalence of rubella virus IgG in pregnant women in Harare, Zimbabwe. GERMS. 2015;5(2):50-52.
Mugomeri E, Chatanga P, Lefunyane M, Ruhanya V, Nyandoro G, Chin’ombe N. Adherence to tuberculosis infection control guidelines by nurses in Lesotho. American Journal of Infection Control. 2015, 43(7):735-738.
Midzi N, Mtapuri –Zinyowera S, Mutsaka MJ, Ruhanya V, Magwenzi M, Chin’ombe N, Nyandoro G, Marume A, Kumar N and Mduluza T. Impact of School Based Health Education on Knowledge, Attitude and Practice of Grade Three Primary School Children in Zimbabwe. J Community Med Health Educ. 2014, 4: 295.
Chin’ombe N, Sebata NL, Ruhanya V, Matarira HT. Human Papillomavirus Genotypes in Cervical Cancer and Vaccination Challenges in Zimbabwe. Infectious Agents and Cancer. Infectious Agents and Cancer. 2014, 9:16.
Chapman R, Bourn WR, Shephard E, Stutz H, Douglass N, Mgwebi T, Meyers A, Chin'ombe N, Williamson AL. The Use of Directed Evolution to Create a Stable and Immunogenic Recombinant BCG Expressing a Modified HIV-1 Gag Antigen. PLoS One. 2014, 9(7):e103314.
Mhandire K, Duri K, Kandawasvika G, Chandiwana P, Chin’ombe N, Kanyera RB, Stray-Pedersen B, Dandara C. CCR2, CX3CR1, RANTES and SDF1 genetic polymorphisms influence HIV infection in a Zimbabwean pediatric population. J Infect Dev Ctries 2014; 8(10):1313-1321.
Mtapuri-Zinyowera S, Ruhanya V, Midzi N, Berejena C, Chin’ombe N, Nziramasanga P, Nyandoro G, Mduluza T. Human parasitic protozoa in drinking water sources in rural Zimbabwe and their link to HIV infection. GERMS. 2014;4:86-91.
Chin'ombe N. Recombinant Salmonella enterica Serovar Typhimurium as a Vaccine Vector for HIV-1 Gag. Viruses. 2013, 5, 2062-2078.
Chin’ombe N, Lebeko M, Kgatle M. Overexpression of recombinant HIV-1 Subtype C Tat and Nef in a Salmonella vaccine vector. Pan African Medical Journal. 2013, 16:19.
Chin’ombe N, Ruhanya V. Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines. The Open Virology Journal. 2013, 7:121-126.
Chin’ombe N, Msengezi O, Matarira HT. Microalbuminuria in patients with chronic kidney disease at Parirenyatwa Hospital in Zimbabwe. Pan African Medical Journal. 2013, 14,39
Swart M, Skelton M, Wonkam A, Kannemeyer L, Chin’ombe N, Dandara D. CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics. Current Pharmacogenomics and Personalised Medicine 2012 10, 43-53.
Chin’ombe N, Chavhunduka E, Matarira HT. Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe. Infectious Agents and Cancer 2009 4:15
Chin'ombe N, Bourn WR, Williamson AL, Shephard EG. Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice. Virology Journal 2009 6:87.
Chin'ombe N, Bourn WR, Williamson AL, Shephard EG. An oral recombinant Salmonella enterica serovar Typhimurium mutant elicits systemic antigen-specific CD8+ T cell cytokine responses in mice. Gut Pathogens 2009 1:9.
Chin’ombe N, Lebeko M and Williamson A-L. Prokaryotic expression and purification of HIV-1 Subtype C Gag for use in ELISAs. International Journal of Infectious Diseases 12 (Supplement 1), 2008.
Kgatle M, Williamson A-L and Chin’ombe N, Expression of HIV-1 Subtype C Tat and Nef in Salmonella vaccine vector. AIDS Research and Human Retroviruses 24 (Supplement 1), 2008, 88.
Lebeko M, Williamson A-L and Chin’ombe N, Purification of recombinant HIV-1 Subtype C Tat and Nef expressed from Escherichia coli. AIDS Research and Human Retroviruses 24 (Supplement 1), 2008, 96.
Chin’ombe N, Shephard EG, Williamson A-L and Rybicki EP, Immunogenicity of HIV-1 Subtype C Gag plasmo-VLP vaccine. AIDS Research and Human Retroviruses 24 (Supplement 1), 2008, 139.
Matarira HT, Mujaji WB, Chin’ombe N, Mlambo T, Nyamayaro T. The contribution of ZEQAS in the practice of laboratory medicine: 1989-1999. Journal of the Association for Laboratory Automation, 4(4) 1999, 75-77.
Matarira H T, Chin’ombe N. Equipping a laboratory for cancer research in a developing country. Central African Journal of Medicine 44: 1998, 138-139.
Chin’ombe N, Matarira, H. T. Genetic engineering: The biotechnology of miracles, hopes and fears. Central African Journal of Medicine 44, 1998, 188-189.